Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Harmony Biosciences Holdings (HRMY) Income from Continuing Operations (2019 - 2025)

Harmony Biosciences Holdings' Income from Continuing Operations history spans 7 years, with the latest figure at 22486000.0 for Q4 2025.

  • For Q4 2025, Income from Continuing Operations fell 66.1% year-over-year to 22486000.0; the TTM value through Dec 2025 reached 158687000.0, down 2.25%, while the annual FY2025 figure was 158687000.0, 2.25% down from the prior year.
  • Income from Continuing Operations for Q4 2025 was 22486000.0 at Harmony Biosciences Holdings, down from 50865000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 87943000.0 in Q3 2022 and bottomed at 37846000.0 in Q4 2022.
  • The 5-year median for Income from Continuing Operations is 28046000.0 (2023), against an average of 28979450.0.
  • The largest YoY upside for Income from Continuing Operations was 52385.19% in 2021 against a maximum downside of 603.93% in 2021.
  • A 5-year view of Income from Continuing Operations shows it stood at 22714000.0 in 2021, then crashed by 266.62% to 37846000.0 in 2022, then skyrocketed by 170.3% to 26607000.0 in 2023, then soared by 149.26% to 66321000.0 in 2024, then tumbled by 66.1% to 22486000.0 in 2025.
  • Per Business Quant, the three most recent readings for HRMY's Income from Continuing Operations are 22486000.0 (Q4 2025), 50865000.0 (Q3 2025), and 39776000.0 (Q2 2025).